January 5, 2018 / 10:23 PM / Updated 6 minutes ago BRIEF-Alliqua Biomedical Says Has Right To Terminate Agreement With Celularity, Provided Co Pays $1.45 Mln Fee Reuters Staff 1 Min Read 
Jan 5 (Reuters) - Alliqua Biomedical Inc: 
* ALLIQUA BIOMEDICAL SAYS HAS RIGHT TO TERMINATE ASSET PURCHASE AGREEMENT WITH CELULARITY, PROVIDED CO PAYS TERMINATION FEE OF $1.45 MILLION - SEC FILING 
* ALLIQUA BIOMEDICAL INC - CELULARITY MAY BE OBLIGATED TO PAY A $3 MILLION REVERSE TERMINATION FEE IF ASSET PURCHASE AGREEMENT IS TERMINATED BY CO Source text for Eikon: ( bit.ly/2CMZUYM ) Further company coverage: